Shawn Egan

Stock Analyst at Citigroup

(2.09)
# 2,697
Out of 4,829 analysts
4
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
Nov 27, 2024
Maintains: Neutral
Price Target: $27$26
Current: $13.97
Upside: +86.11%